A clinical trial assessing TTX RIGA
Latest Information Update: 19 Oct 2023
At a glance
- Drugs TTX RIGA (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
Most Recent Events
- 19 Oct 2023 New trial record
Latest Information Update: 19 Oct 2023